Hyderabad: After a long wait, the World Health Organization (WHO) on Wednesday gave a prize Diwali to millions of people who were vaccinated by finally providing an emergency use list (EUL) to Covaxin.
NOD has been given for all aged 18 years and over but does not apply to pregnant women.
NOD has come at close to 20 countries have recognized Covaxin.
Recently, an official from WHO said the organization trusted the Indian industry, indicating that the approval was on the card.
Approval does not only open the doors of countries around the world to use Covaxin in their immunization program, but also come as a major pause for those who have taken two vaccine doses but still face restrictions on trips abroad.
“The Technical Advisory Group, which was held by WHO and consisted of regulators from all over the world, has determined that the #Covaxin vaccine meets the protection standard of # Covid19, that the benefits of vaccines far exceed the risks & vaccines are used globally.
#Covaxin also reviewed by whom Expert strategic experts about immunization (wise) and recommend the use of this vaccine in two doses, with a four-week dose interval, in all groups of age 18 and above, “said in a tweet.
Also read Covaxin’s Covaxin gets who is approved: Who said whatnew Delhi: The World Health Organization (WHO) on Wednesday approved the Indian Covid-19 vaccine developed by Bharat Biotech.
The WHO decision has been welcomed by the government.
This is what says: Bharat Biotech: Vaccine developers, Bharat Biotech said that pregnant women, who said the available data was not enough to assess his safety or efficacy and that studies in pregnant women were planned, including pregnancy sub-studies and a registry of pregnancy.
The emergency list was postponed last month because the technical advisory group asked for several additional clarification from Bharat Biotech for the final risk assessment.
Advisory groups have searched for more clinical trial data from companies by gender and age groups.
Even though it took around 90-100 days for who Eul for Covaxin, the UN agency stated that it was not the only vaccine that had taken so much time to receive approval and there were others who had been taking longer.
Bharat Biotech has handed over the expression on April 19 this year and sending data rolling starts on July 6.
Bharat Biotech said validation from WHO, countries can accelerate the process of approval of their regulations to import and manage their vaccines.
Organizations such as UNICEF, PAN-American health organizations and Gavi Covax facilities will be able to obtain vaccines for global distribution for priority populations, ensuring fair access.
Bharat Biotech Chairman and Managing Director Dr.
Krishna Ella said, “Validation by WHO is a very significant step to ensure global access to Covaxin which is managed widely, safely, and efficacious.
EUL will enable us to contribute to accelerating fair access from Covid.
-19 vaccines, and access to our vaccines globally, thus discussing the current public health emergency.
“The company said after starting the expansion of its manufacturing capacity in Q1 2021, it has increased it to 50-55 million doses per month in October 2021.
Annual capacity of one billion doses by the end of 2021 and also in the process of carrying out technology transfer to companies in India, US and others.